Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
(2016) In Molecular Neurodegeneration 11(1).- Abstract
- Despite decades of intensive research, to date, there is no accepted diagnosis for Parkinson's disease (PD) based on biochemical analysis of blood or CSF. However, neurodegeneration in the brains of PD patients begins several years before the manifestation of the clinical symptoms, pointing to serious flaw/limitations in this approach.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8577042
- author
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Molecular Neurodegeneration
- volume
- 11
- issue
- 1
- article number
- 7
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:26782965
- wos:000368974800001
- scopus:84954348724
- pmid:26782965
- ISSN
- 1750-1326
- DOI
- 10.1186/s13024-016-0072-9
- language
- English
- LU publication?
- yes
- id
- 8dd20982-3de5-4550-a8e6-92261ef9cd58 (old id 8577042)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26782965?dopt=Abstract
- date added to LUP
- 2016-04-01 13:54:04
- date last changed
- 2022-05-19 21:47:08
@article{8dd20982-3de5-4550-a8e6-92261ef9cd58, abstract = {{Despite decades of intensive research, to date, there is no accepted diagnosis for Parkinson's disease (PD) based on biochemical analysis of blood or CSF. However, neurodegeneration in the brains of PD patients begins several years before the manifestation of the clinical symptoms, pointing to serious flaw/limitations in this approach.}}, author = {{Majbour, Nour K and Vaikath, Nishant N. and van Dijk, Karin D and Ardah, Mustafa T and Varghese, Shiji and Vesterager, Louise B and Montezinho, Liliana P and Poole, Stephen and Safieh-Garabedian, Bared and Tokuda, Takahiko and Teunissen, Charlotte E and Berendse, Henk W and van de Berg, Wilma D J and El-Agnaf, Omar M A}}, issn = {{1750-1326}}, language = {{eng}}, number = {{1}}, publisher = {{BioMed Central (BMC)}}, series = {{Molecular Neurodegeneration}}, title = {{Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.}}, url = {{http://dx.doi.org/10.1186/s13024-016-0072-9}}, doi = {{10.1186/s13024-016-0072-9}}, volume = {{11}}, year = {{2016}}, }